Blog
EQS-News: KION Group appoints new Chief Financial Officer and Chief People and Sustainability Officer
EQS-News: KION Group appoints new Chief Financial Officer and Chief People and Sustainability Officer
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
EQS-Adhoc: Diebold Nixdorf entered into agreement to support debt refinancing for certain near-term maturities as well as to provide $400 million additional financing and revises 2022 outlook
EQS-Adhoc: Diebold Nixdorf entered into agreement to support debt refinancing for certain near-term maturities as well as to provide $400 million additional financing and revises 2022 outlook
EQS-Adhoc: GFT Technologies SE raises earnings forecast for 2022
EQS-Adhoc: GFT Technologies SE raises earnings forecast for 2022
EQS-News: Linde’s Climate Goal Approved by Science Based Targets initiative
EQS-News: Linde’s Climate Goal Approved by Science Based Targets initiative
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
EQS-News: Siltronic AG: EIB supports development of Siltronic’s next generation of silicon wafers
EQS-News: Siltronic AG: EIB supports development of Siltronic’s next generation of silicon wafers
EQS-News: Mensch und Maschine Software SE presenting 9M report 2022
EQS-News: Mensch und Maschine Software SE presenting 9M report 2022
Voyageurs du Monde: Business picking up significantly
Voyageurs du Monde: Business picking up significantly
EQS-News: 2G Energy AG boosts Q3 net sales by around 50 % to approximately EUR 79 million (previous year: EUR 51.5 million)
EQS-News: 2G Energy AG boosts Q3 net sales by around 50 % to approximately EUR 79 million (previous year: EUR 51.5 million)
EQS-News: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: LUDWIG BECK - Normalisation of sales and earnings development during the third quarter of the fiscal year 2022
EQS-News: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: LUDWIG BECK - Normalisation of sales and earnings development during the third quarter of the fiscal year 2022
EQS-News: niiio subsidiary PATRONAS wins innovation driver from Austria as a new customer and records increasing momentum in the pan-European market
EQS-News: niiio subsidiary PATRONAS wins innovation driver from Austria as a new customer and records increasing momentum in the pan-European market
SWEF: Transaction in Own Shares
SWEF: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Travis Perkins plc Q3 2022 trading update
Travis Perkins plc Q3 2022 trading update
Nordea Bank Abp: Repurchase of own shares on 19.10.2022
Nordea Bank Abp: Repurchase of own shares on 19.10.2022
Nordea Bank Abp: Third-quarter results 2022
Nordea Bank Abp: Third-quarter results 2022
EQS-News: First successful year on the market for Marinomed’s Solv4U technology partnerships
EQS-News: First successful year on the market for Marinomed’s Solv4U technology partnerships
EQS-News: DIC Asset AG sets standards for sustainable building management
EQS-News: DIC Asset AG sets standards for sustainable building management
EQS-News: Northern Data: Adoption of all proposed resolutions at first virtual Annual General Meeting under new stock corporation law regulations
EQS-News: Northern Data: Adoption of all proposed resolutions at first virtual Annual General Meeting under new stock corporation law regulations
CMG Cleantech S.A. Enters into Discussions for Large Scale Solar Panel Installations
CMG Cleantech S.A. Enters into Discussions for Large Scale Solar Panel Installations
EQS-News: ENCAVIS AG finances two solar parks in Denmark
EQS-News: ENCAVIS AG finances two solar parks in Denmark
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis
Cosmo announces FDA grants orphan-drug designation of
rifamycin for treatment of pouchitis
With accelerated Growth and despite ongoing Bottlenecks Well on Track for Full Year 2022
With accelerated Growth and despite ongoing Bottlenecks Well on Track for Full Year 2022


